Man Group PLC Exact Sciences Corp Transaction History

Man Group PLC

$37.6 Billion
Q2 2024

A detailed history of Man Group PLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Man Group PLC holds 13,539 shares of EXAS stock, worth $686,833. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,539

Previous 92,949 85.43%

Holding current value

$686,833

Previous $6.42 Million 91.09%

% of portfolio

0.0%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$41.33 - $74.26 $3.28 Million - $5.9 Million	-79,410 Reduced 85.43%	13,539 $572,000
Q1 2024 May 15, 2024	SELL	$56.27 - $73.77 $12.7 Million - $16.7 Million	-226,130 Reduced 70.87%	92,949 $6.42 Million
Q4 2023 Feb 14, 2024	SELL	$59.06 - $75.72 $5.31 Million - $6.81 Million	-89,877 Reduced 21.98%	319,079 $23.6 Million
Q3 2023 Nov 14, 2023	BUY	$65.94 - $99.04 $5.81 Million - $8.73 Million	88,158 Added 27.48%	408,956 $27.9 Million
Q2 2023 Aug 14, 2023	BUY	$62.68 - $95.05 $14.6 Million - $22.2 Million	233,601 Added 267.9%	320,798 $30.1 Million
Q1 2023 May 15, 2023	SELL	$47.19 - $70.77 $9.86 Million - $14.8 Million	-209,030 Reduced 70.56%	87,197 $5.91 Million
Q4 2022 Feb 14, 2023	BUY	$30.35 - $53.15 $4.22 Million - $7.39 Million	139,086 Added 88.51%	296,227 $14.7 Million
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $4.68 Million - $7.23 Million	146,351 Added 1356.36%	157,141 $5.11 Million
Q2 2022 Aug 15, 2022	BUY	$35.61 - $76.23 $384,231 - $822,521	10,790 New	10,790 $425,000
Q1 2022 May 16, 2022	SELL	$57.56 - $82.54 $646,859 - $927,584	-11,238 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $2.86 Million - $3.97 Million	-39,419 Reduced 77.82%	11,238 $875,000
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $1.98 Million - $2.73 Million	21,992 Added 76.72%	50,657 $4.84 Million
Q2 2021 Aug 16, 2021	BUY	$93.66 - $139.27 $2.51 Million - $3.73 Million	26,807 Added 1442.79%	28,665 $3.56 Million
Q1 2021 May 17, 2021	SELL	$116.57 - $155.01 $2.08 Million - $2.76 Million	-17,801 Reduced 90.55%	1,858 $245,000
Q4 2020 Feb 16, 2021	SELL	$99.61 - $142.12 $485,499 - $692,692	-4,874 Reduced 19.87%	19,659 $2.61 Million
Q3 2020 Nov 16, 2020	SELL	$72.92 - $102.01 $1.74 Million - $2.44 Million	-23,895 Reduced 49.34%	24,533 $2.5 Million
Q2 2020 Aug 14, 2020	BUY	$55.75 - $92.75 $2.45 Million - $4.07 Million	43,875 Added 963.65%	48,428 $4.21 Million
Q1 2020 May 15, 2020	BUY	$37.9 - $104.44 $71,289 - $196,451	1,881 Added 70.4%	4,553 $264,000
Q4 2019 Feb 18, 2020	BUY	$77.66 - $99.74 $207,507 - $266,505	2,672 New	2,672 $247,000
Q2 2019 Aug 14, 2019	SELL	$89.51 - $118.04 $1.9 Million - $2.51 Million	-21,257 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$61.98 - $96.5 $817,268 - $1.27 Million	13,186 Added 163.38%	21,257 $1.84 Million
Q4 2018 Feb 14, 2019	SELL	$56.04 - $82.66 $64,614 - $95,306	-1,153 Reduced 12.5%	8,071 $509,000
Q3 2018 Nov 14, 2018	BUY	$48.29 - $80.6 $445,426 - $743,454	9,224 New	9,224 $728,000
Q2 2018 Aug 14, 2018	SELL	$37.84 - $69.96 $413,704 - $764,872	-10,933 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$39.82 - $57.53 $435,352 - $628,975	10,933 New	10,933 $441,000

Others Institutions Holding EXAS

# of Institutions

665

Shares Held

166M

Call Options Held

2.61M

Put Options Held

1.31M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.98B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account